The American Cancer Society Cancer Action Network (ACS CAN), the nation’s leading cancer advocacy organization, strongly opposes two bills being considered by the Wisconsin Legislature that pose life-threatening risks to cancer patients, survivors and those who will be diagnosed with cancer or other chronic diseases.
State Senator Monique Limón introduced Senate Bill 912 to increase access to biomarker testing, which can help determine the best treatment plan for a specific patient. ACS CAN and the University of California have teamed up to sponsor this important step in ensuring cancer patients have access to precision medicine.
ACS CAN espera trabajar con el nuevo alcalde de la ciudad de Nueva York y la portavoz del consejo municipal en temas fundamentales de la salud.
COLUMBUS, OHIO – “Today, the Ohio House passed HB 218, which allows vague and subjective exemptions to vaccine requirements based on reasons of conscience.
COLUMBUS, OHIO – “Today, the Ohio House paused HB 435, which allows vague and subjective exemptions to vaccine mandates based on reasons of conscience.
This year roughly 10,240 Idahoans will be diagnosed with cancer. Thanks in part to advances in cancer research and treatment, we are saving more lives than ever.
ACS CAN has kicked off NYC Week of Action by delivering letters to Mayor de Blasio and Speaker Johnson asking for support for tobacco control as well as early detection and preveention.
LANSING, MI – The American Cancer Society Cancer Action Network (ACS CAN) is thrilled to see the House pass oral chemotherapy fairness legislation today. ACS CAN wants to take this moment to thank Rep. Daire Rendon for supporting and sponsoring this legislation.
SPRINGFIELD, IL – As lawmakers dive into the new year, the American Cancer Society Cancer Action Network (ACS CAN) asks that legislators support legislation that will ease the cancer burden in Illinois.
The U.S. Senate passed legislation tonight aimed at improving access to clinical trials for communities of color and decreasing health disparities.